Development and validation of a novel HPLC method to analyse metabolic reaction products catalysed by the CYP3A2 isoform: in vitro inhibition of CYP3A2 enzyme activity by aspirin (drugs often used together in COVID-19 treatment)

Amira Hussain; Declan P. Naughton; James Barker

doi:10.3390/molecules27030927

Development and validation of a novel HPLC method to analyse metabolic reaction products catalysed by the CYP3A2 isoform: in vitro inhibition of CYP3A2 enzyme activity by aspirin (drugs often used together in COVID-19 treatment)

Amira Hussain
, Declan P. Naughton
, James Barker

Kingston University

Research output: Contribution to journal › Article › peer-review

1 Downloads (Pure)

Original language	English
Article number	927
Journal	Molecules
Volume	27
Issue number	3
Early online date	29 Jan 2022
DOIs	https://doi.org/10.3390/molecules27030927
Publication status	Published - 2 Feb 2022

Keywords

Biological sciences

Access to Document

10.3390/molecules27030927

Hussein-A-51063-VoRFinal published version, 1.26 MBLicence: CC BY

https://doi.org/10.3390/molecules27030927

Cite this

@article{3903f8eac2a8453ba7a2581bfe892550,

title = "Development and validation of a novel HPLC method to analyse metabolic reaction products catalysed by the CYP3A2 isoform: in vitro inhibition of CYP3A2 enzyme activity by aspirin (drugs often used together in COVID-19 treatment)",

keywords = "Biological sciences",

author = "Amira Hussain and Naughton, \{Declan P.\} and James Barker",

year = "2022",

month = feb,

day = "2",

doi = "10.3390/molecules27030927",

language = "English",

volume = "27",

journal = "Molecules",

issn = "1420-3049",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "3",

}

Development and validation of a novel HPLC method to analyse metabolic reaction products catalysed by the CYP3A2 isoform: in vitro inhibition of CYP3A2 enzyme activity by aspirin (drugs often used together in COVID-19 treatment). / Hussain, Amira; Naughton, Declan P.; Barker, James.
In: Molecules, Vol. 27, No. 3, 927, 02.02.2022.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Development and validation of a novel HPLC method to analyse metabolic reaction products catalysed by the CYP3A2 isoform

T2 - in vitro inhibition of CYP3A2 enzyme activity by aspirin (drugs often used together in COVID-19 treatment)

AU - Hussain, Amira

AU - Naughton, Declan P.

AU - Barker, James

PY - 2022/2/2

Y1 - 2022/2/2

KW - Biological sciences

UR - http://www.mdpi.com/journal/molecules

U2 - 10.3390/molecules27030927

DO - 10.3390/molecules27030927

M3 - Article

SN - 1420-3049

VL - 27

JO - Molecules

JF - Molecules

IS - 3

M1 - 927

ER -

Development and validation of a novel HPLC method to analyse metabolic reaction products catalysed by the CYP3A2 isoform: in vitro inhibition of CYP3A2 enzyme activity by aspirin (drugs often used together in COVID-19 treatment)

Keywords

Access to Document

Other files and links

Cite this